vs

Side-by-side financial comparison of T Stamp Inc (IDAI) and INVO Fertility, Inc. (IVF). Click either name above to swap in a different company.

INVO Fertility, Inc. is the larger business by last-quarter revenue ($1.8M vs $908.9K, roughly 1.9× T Stamp Inc). INVO Fertility, Inc. runs the higher net margin — -150.5% vs -279.9%, a 129.4% gap on every dollar of revenue. On growth, INVO Fertility, Inc. posted the faster year-over-year revenue change (22.6% vs -39.3%). T Stamp Inc produced more free cash flow last quarter ($2.0M vs $-1.8M). Over the past eight quarters, T Stamp Inc's revenue compounded faster (25.9% CAGR vs 12.8%).

T Stamp Inc, trading under ticker IDAI, develops AI-powered identity verification, trust scoring, and fraud prevention solutions. It serves clients across fintech, healthcare, and e-commerce segments, primarily operating in North America to help organizations securely authenticate user identities and mitigate fraud risks.

INVO Fertility, Inc. is a specialized healthcare company focused on delivering accessible assisted reproductive technology solutions. It develops, manufactures and markets the patented INVOcell intravaginal culture system for in vitro fertilization procedures, serving fertility clinics and patients across North America, Europe and other global regions, with a mission to reduce barriers to high-quality fertility care.

IDAI vs IVF — Head-to-Head

Bigger by revenue
IVF
IVF
1.9× larger
IVF
$1.8M
$908.9K
IDAI
Growing faster (revenue YoY)
IVF
IVF
+61.9% gap
IVF
22.6%
-39.3%
IDAI
Higher net margin
IVF
IVF
129.4% more per $
IVF
-150.5%
-279.9%
IDAI
More free cash flow
IDAI
IDAI
$3.7M more FCF
IDAI
$2.0M
$-1.8M
IVF
Faster 2-yr revenue CAGR
IDAI
IDAI
Annualised
IDAI
25.9%
12.8%
IVF

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
IDAI
IDAI
IVF
IVF
Revenue
$908.9K
$1.8M
Net Profit
$-2.5M
$-2.6M
Gross Margin
Operating Margin
-224.9%
-93.1%
Net Margin
-279.9%
-150.5%
Revenue YoY
-39.3%
22.6%
Net Profit YoY
57.7%
-62.2%
EPS (diluted)
$-0.37
$-0.77

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IDAI
IDAI
IVF
IVF
Q4 25
$908.9K
Q3 25
$872.5K
$1.8M
Q2 25
$812.7K
$1.9M
Q1 25
$545.5K
$1.6M
Q4 24
$1.5M
$1.7M
Q3 24
$511.1K
$1.4M
Q2 24
$500.4K
$1.8M
Q1 24
$573.7K
$1.6M
Net Profit
IDAI
IDAI
IVF
IVF
Q4 25
$-2.5M
Q3 25
$-1.9M
$-2.6M
Q2 25
$-1.7M
$-5.3M
Q1 25
$-2.2M
$-17.4M
Q4 24
$-6.0M
$-3.6M
Q3 24
$-1.3M
$-1.6M
Q2 24
$-2.6M
$-2.2M
Q1 24
$-2.7M
$-1.6M
Gross Margin
IDAI
IDAI
IVF
IVF
Q4 25
Q3 25
Q2 25
Q1 25
35.2%
Q4 24
41.4%
Q3 24
31.0%
Q2 24
53.1%
Q1 24
45.3%
Operating Margin
IDAI
IDAI
IVF
IVF
Q4 25
-224.9%
Q3 25
-203.0%
-93.1%
Q2 25
-207.0%
-160.4%
Q1 25
-396.5%
-1042.1%
Q4 24
-81.2%
-202.0%
Q3 24
-523.7%
-90.7%
Q2 24
-524.7%
-100.9%
Q1 24
-496.7%
-95.7%
Net Margin
IDAI
IDAI
IVF
IVF
Q4 25
-279.9%
Q3 25
-219.1%
-150.5%
Q2 25
-210.7%
-283.6%
Q1 25
-395.5%
-1060.1%
Q4 24
-401.5%
-211.3%
Q3 24
-245.7%
-113.8%
Q2 24
-519.3%
-122.2%
Q1 24
-466.9%
-101.3%
EPS (diluted)
IDAI
IDAI
IVF
IVF
Q4 25
$-0.37
Q3 25
$-0.72
$-0.77
Q2 25
$-0.69
$-13.30
Q1 25
$-0.89
$-12.53
Q4 24
$-3.14
$14.86
Q3 24
$-1.06
$-15.11
Q2 24
$-3.19
$-22.39
Q1 24
$-3.97
$-7.55

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IDAI
IDAI
IVF
IVF
Cash + ST InvestmentsLiquidity on hand
$6.0M
Total DebtLower is stronger
$2.0M
Stockholders' EquityBook value
$8.7M
$5.8M
Total Assets
$11.2M
$18.8M
Debt / EquityLower = less leverage
0.34×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IDAI
IDAI
IVF
IVF
Q4 25
$6.0M
Q3 25
$5.4M
Q2 25
$292.1K
Q1 25
$1.1M
Q4 24
$2.8M
Q3 24
$598.0K
Q2 24
$659.5K
Q1 24
$816.7K
Total Debt
IDAI
IDAI
IVF
IVF
Q4 25
Q3 25
$2.0M
Q2 25
$4.8M
Q1 25
Q4 24
$7.5M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
IDAI
IDAI
IVF
IVF
Q4 25
$8.7M
Q3 25
$6.1M
$5.8M
Q2 25
$2.4M
$2.6M
Q1 25
$4.1M
$3.3M
Q4 24
$3.0M
$12.7M
Q3 24
$5.4M
$-23.3K
Q2 24
$750.4K
$1.4M
Q1 24
$1.4M
$10.2K
Total Assets
IDAI
IDAI
IVF
IVF
Q4 25
$11.2M
Q3 25
$11.2M
$18.8M
Q2 25
$5.7M
$19.3M
Q1 25
$6.6M
$31.7M
Q4 24
$8.6M
$46.4M
Q3 24
$10.6M
$17.0M
Q2 24
$5.2M
$17.8M
Q1 24
$5.6M
$17.3M
Debt / Equity
IDAI
IDAI
IVF
IVF
Q4 25
Q3 25
0.34×
Q2 25
1.83×
Q1 25
Q4 24
0.59×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IDAI
IDAI
IVF
IVF
Operating Cash FlowLast quarter
$2.0M
$-1.8M
Free Cash FlowOCF − Capex
$2.0M
$-1.8M
FCF MarginFCF / Revenue
215.4%
-101.6%
Capex IntensityCapex / Revenue
0.8%
0.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-5.7M
$-7.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IDAI
IDAI
IVF
IVF
Q4 25
$2.0M
Q3 25
$-4.0M
$-1.8M
Q2 25
$-2.1M
$-1.7M
Q1 25
$-1.5M
$-3.5M
Q4 24
$-2.7M
$-617.4K
Q3 24
$-2.4M
$-640.8K
Q2 24
$-1.6M
$-1.5M
Q1 24
$-2.2M
$-260.6K
Free Cash Flow
IDAI
IDAI
IVF
IVF
Q4 25
$2.0M
Q3 25
$-4.0M
$-1.8M
Q2 25
$-2.1M
$-1.7M
Q1 25
$-1.6M
$-3.6M
Q4 24
$-2.7M
$-696.3K
Q3 24
$-2.4M
Q2 24
$-1.6M
$-1.5M
Q1 24
$-2.2M
$-310.3K
FCF Margin
IDAI
IDAI
IVF
IVF
Q4 25
215.4%
Q3 25
-459.6%
-101.6%
Q2 25
-258.6%
-92.6%
Q1 25
-289.2%
-216.9%
Q4 24
-182.9%
-40.6%
Q3 24
-475.4%
Q2 24
-320.9%
-82.3%
Q1 24
-376.6%
-19.7%
Capex Intensity
IDAI
IDAI
IVF
IVF
Q4 25
0.8%
Q3 25
0.0%
0.5%
Q2 25
0.2%
0.5%
Q1 25
6.8%
0.9%
Q4 24
0.1%
4.6%
Q3 24
0.7%
0.0%
Q2 24
1.3%
3.0%
Q1 24
0.5%
3.2%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons